MOMENTUS Appoints Ed Shifflett, PhD as Chief Growth Officer and Managing Partner

MOMENTUS Strengthens Leadership with New Appointment

In a significant move for the firm, MOMENTUS BioPharma Consulting Group has officially welcomed Ed Shifflett, PhD, into their ranks as the Chief Growth Officer and Managing Partner. The announcement, made on July 23, 2026, emphasizes MOMENTUS's commitment to bolstering their leadership team amid the evolving landscape of the biopharma industry.

Embracing Growth

John "Zeke" Czekanski, CEO of MOMENTUS, expressed enthusiasm about Shifflett's appointment, citing the impressive growth trajectory of the company. He acknowledged that clients have positively responded to the innovative strategies proposed by MOMENTUS, noting the need for forward-thinking solutions that integrate seamlessly across the therapeutic lifecycle.

Czekanski stated, "The growth and trajectory of the company support Ed joining us as Chief Growth Officer and a full partner. Clients have responded extremely well to our forward-thinking strategies driven by innovative and integrated solutions across the therapeutic lifecycle. Ed’s experience building and scaling successful, client-focused businesses positions us well for the future."

A Unique Expertise

Shifflett brings a wealth of experience and knowledge to the position, having earned his PhD in Gastrointestinal Physiology from North Carolina State University. His postdoctoral endeavors included extensive research on the microbiological impacts on gastrointestinal function at the University of Illinois-Chicago Medical Center. This robust scientific background, combined with his transition into business leadership roles, positions him uniquely to lead MOMENTUS into a new era of consultancy in the biopharma space.

Prior to joining MOMENTUS, Shifflett co-founded AlphaGroup Medical Communications, where he contributed to the company’s significant growth across various global biopharma clients. Under his guidance, AlphaGroup became known for its performance-driven culture and its adeptness in translating complex scientific concepts into actionable commercial strategies. In 2022, his leadership there culminated in the company’s acquisition by Red Nucleus, where he continued to drive growth and expand service offerings.

Meeting Industry Challenges

In his role at MOMENTUS, Shifflett aims to leverage his unique insights to aid clients in accelerating the approval, access, and adoption of vital therapies. Scott Roberts, Chief Strategy Officer and Managing Partner at MOMENTUS, emphasized the critical nature of Shifflett's role, stating, "The timing for Ed to join is significant as the pace and magnitude of industry transformation are raising the bar and driving demand for a new kind of consultancy."

Shifflett highlighted the importance of integrating data and advanced analytics in modern decision-making processes, particularly as the biopharma industry shifts towards using such tools. He noted, "We’re entering a new era in biopharma—one defined by data, speed, and the need for more integrated thinking. AI and advanced analytics are reshaping how decisions are made across the therapeutic lifecycle."

Looking Ahead

Moving forward, Shifflett's vision includes ensuring that MOMENTUS remains at the forefront of the industry's transformation by balancing speed, insightful analysis, and human judgment. He aims to enhance the MOMENTUS Readiness Platform, which incorporates AI technologies alongside expert human insights to provide effective solutions for clients aiming to bring innovative therapies to market.

"I’m excited to help our clients navigate this transformation and ultimately improve how therapies reach and impact patients while building an organization that attracts and develops exceptional talent," said Shifflett in closing.

About MOMENTUS

Headquartered in Lantana, FL, with additional locations in Boston, MA, and now Philadelphia, PA, MOMENTUS is committed to offering integrated strategic solutions across the therapeutic lifecycle. Their innovative MOMENTUS Readiness Platform utilizes the latest technologies and subject-matter expertise to ensure clients receive comprehensive strategies aimed at enhancing patient outcomes. For more information on MOMENTUS and their services, visit their official website and LinkedIn page.